Eli Lilly and Co
Stocks making the biggest moves midday: Oracle, Vail Resorts, GE Vernova, Brinks, Ciena & more
Check out the companies making the biggest moves midday: Oracle — The database management software maker tumbled 14% after reporting fiscal second-quarter revenue that missed analyst expectations. Multiple analysts across Wall Street raced to lower their price targets in reaction. Vail Resorts — The ski resort owner jumped 9%. Fiscal first quarter “mountain” revenue of […]
Read More
Stocks making the biggest moves premarket: Oracle, Oxford Industries, Adobe, Gemini Space Station & more
Check out the companies making headlines before the bell: Oracle — The software giant tumbled more than 12% after reporting fiscal second-quarter revenue that missed analyst expectations. Analysts across Wall Street raced to lower their price targets. Adobe — Shares fell slightly after the software company issued lackluster guidance for fiscal year 2026. Adobe sees […]
Read More
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]
Read More
Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Thursday said its next-generation obesity drug delivered strong weight loss and reduced knee arthritis pain in a late-stage study, clearing the first of several upcoming trials on the weekly injection. The […]
Read More
The Fed meeting, pressure on Oracle, Target’s fashion-forward renovation and more in Morning Squawk
Television stations broadcast Jerome Powell, chairman of the US Federal Reserve, speaking after a Federal Open Market Committee (FOMC) meeting on the floor of the New York Stock Exchange in New York, US, on Wednesday, Oct. 29, 2025. Michael Nagle | Bloomberg | Getty Images This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions […]
Read More
Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Tuesday said it will spend […]
Read More
Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company’s pill
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Reuters Pfizer on Tuesday said it has struck an […]
Read More
Unilever spinoff Magnum Ice Cream debuts on Amsterdam stock market
Packets of Walls Cornetto, Magnum and Ben & Jerry’s ice cream are displayed on March 20, 2024. John Keeble | Getty Images News | Getty Images Magnum Ice Cream Company, now the world’s largest standalone ice cream business, debuted on the Amsterdam stock exchange on Monday. The stock opened at 12.20 euros, slightly below its […]
Read More
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the […]
Read More
Eli Lilly’s price cut, Thanksgiving box office, trouble for gravestone makers and more in Morning Squawk
Sopa Images | Lightrocket | Getty Images This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things investors need to know to start the trading day: 1. No-tech November Last week’s recovery rally allowed the Dow Jones Industrial Average and S&P 500 to both finish their seventh […]
Read More